May 2010

A Cancer Target Pulls a 180

May 27, 2010

Scientists will be the first to admit that science sometimes makes mistakes. Though debates and changing theories are often seized upon by everyone from anti-vaxxers and climate change skeptics as flaws in the scientific process, the constant [Read more]

The Promise of a Near-Miss

May 26, 2010

A critical step in the design of any clinical trial is picking the right primary endpoint, the result that will usually make or break the study. That’s more difficult than it sounds – one’s hope is to cure a disease or relieve a [Read more]

Videos: Heart Health & Risk

May 24, 2010

Last October, a group of Illinois legislators visited the University of Chicago Medical Center for two days of education and discussion about cardiovascular medicine and health care reform, part of a nationwide “Legislator in the Lab” [Read more]

Q&A: A New Kind of Cancer Vaccine

May 19, 2010

At the end of April, an FDA approval marked the end of a long regulatory road for an interesting drug with an even more interesting history: Provenge. Though it’s usually described as a vaccine for metastatic prostate cancer, that terminology [Read more]

From the Rain Forest to the Laboratory

May 18, 2010

Venomous animals such as snakes, scorpions and spiders are typically the stuff of phobias for most people. But the toxins those creatures have developed to immobilize and kill their prey are actually some of nature’s most finely-tuned weapons, [Read more]